Fidelity Investments
SMTI icon

Fidelity Investments’s Sanara MedTech SMTI Stock Holding History

Fidelity Investments’s Portfolio SMTI Stock Details SMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.6K Buy
1,127
+235
+26% +$4.86K ﹤0.01% 4565
2026
Q1 		$15.3K Sell
892
-738
-45% -$15.2K ﹤0.01% 4618
2025
Q4 		$38.1K Buy
1,630
+1,363
+510% +$35.2K ﹤0.01% 4219
2025
Q3 		$8.47K Sell
267
-213
-44% -$6.43K ﹤0.01% 4654
2025
Q2 		$13.6K Buy
480
+320
+200% +$9.6K ﹤0.01% 4432
2025
Q1 		$4.94K Sell
160
-97
-38% -$3.29K ﹤0.01% 4710
2024
Q4 		$8.53K Buy
257
+86
+50% +$2.92K ﹤0.01% 4516
2024
Q3 		$5.17K Buy
171
+9
+6% +$281 ﹤0.01% 4621
2024
Q2 		$4.57K Sell
162
-149
-48% -$4.68K ﹤0.01% 4566
2024
Q1 		$11.5K Buy
311
+25
+9% +$935 ﹤0.01% 4225
2023
Q4 		$11.8K Sell
286
-267
-48% -$8.57K ﹤0.01% 4186
2023
Q3 		$17.2K Buy
+553
New +$21.4K ﹤0.01% 3883
2021
Q4 		– Sell
-68,215
Closed -$2.32M – 4880
2021
Q3 		$2.32M Buy
+68,215
New +$2.45M ﹤0.01% 2536
2021
Q1 		– Sell
-50
Closed -$2K – 4490
2020
Q4 		$2K Buy
+50
New +$1.97K ﹤0.01% 3612

Other funds holding SMTI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
SWM
Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Fidelity Investments's SMTI Position: Q2 2026 in Review

Fidelity Investments increased its Sanara MedTech (SMTI) stake by 26% in Q2 2026, buying an estimated $4.86K and bringing the position to 1,127 shares worth $26.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4565.

Fidelity Investments first reported a position in SMTI in Q4 2020 and has held it in 14 quarters since. The position peaked at $2.32M in Q3 2021. 74 funds tracked by Wall St. Rank hold SMTI as of Q2 2026.

  • Fidelity Investments held 1,127 shares of Sanara MedTech worth $26.6K as of Q2 2026.
  • Fidelity Investments bought 235 Sanara MedTech shares in Q2 2026, an estimated $4.86K.
  • Sanara MedTech made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #4565 holding.
  • Fidelity Investments first reported a position in Sanara MedTech in Q4 2020 and has held it in 14 quarters since.
  • Fidelity Investments's Sanara MedTech position peaked at $2.32M in Q3 2021.
  • 74 funds tracked by Wall St. Rank held Sanara MedTech as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.